This will take effect October 26, 2012
Overview and Clinical Utility:
The Cervical DNA Dtex testing process has recently been improved and enhanced. These improvements resulted in a lower abnormal cell threshold for test positivity as well as the establishment of a new threshold for test positivity based on excessive tetraploidy, as follows:
Click Here to read more.